Kathleen A. Taylor

Teriparatide or Alendronate in Glucocorticoid-Induced Osteoporosis

Kenneth G. Saag, Elizabeth Shane, Steven Boonen et al. · New England Journal of Medicine · 2007 · 908 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +12

The EspB Protein of Enteropathogenic <i>Escherichia coli</i> Is Targeted to the Cytoplasm of Infected HeLa Cells

Kathleen A. Taylor, Colin B. O’Connell, Paul W. Luther et al. · Infection and Immunity · 1998 · 93 citations · Full text

Life Sciences, Microbiology, Molecular Biology +15

Trabecular Bone Score in Patients With Chronic Glucocorticoid Therapy–Induced Osteoporosis Treated With Alendronate or Teriparatide

Kenneth G. Saag, D. Agnusdei, Didier Hans et al. · Arthritis & Rheumatology · 2016 · 89 citations

Medicine, Pharmacotherapy, Bone Augmentation +16

Skeletal Histomorphometry in Subjects on Teriparatide or Zoledronic Acid Therapy (SHOTZ) Study: A Randomized Controlled Trial

David W. Dempster, Hua Zhou, Robert R. Recker et al. · The Journal of Clinical Endocrinology & Metabolism · 2012 · 80 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Remodeling- and Modeling-Based Bone Formation With Teriparatide Versus Denosumab: A Longitudinal Analysis From Baseline to 3 Months in the AVA Study

David W. Dempster, Hua Zhou, Robert R. Recker et al. · Journal of Bone and Mineral Research · 2017 · 79 citations · Full text

Medicine, Pharmacology, Bone Metabolism +16